An image of a hand pulling a box of Opill off the shelf at a store.

Facts

Dr. Raegan McDonald-Mosley, CEO of Power to Decide, OBGYN, and a leading advocate for reproductive well-being, addresses the arrival of Opill, a progestin-only birth control pill set to be available over the counter (OTC). She delineates its unique characteristics compared to other birth control methods, emphasizing safety and debunking common myths surrounding contraception. Dr. Raegan predicts that the launch of the OTC birth control pill will significantly impact accessibility for millions facing systemic barriers to reproductive health care. Additionally, she provides essential information on pregnancy, shedding light on crucial aspects of reproductive biology amidst a landscape often clouded by misinformation.

Opill is a progestin-only birth control pill, also known as a 'mini-pill.' How does Opill – soon to be available over the counter on store shelves – differ from other birth control pills? Dr. Raegan McDonald-Mosley — CEO of Power to Decide and one of the nation’s top medical leaders on access to reproductive health — shares some need-to-know facts about Opill and explains what differentiates it from other types of hormonal birth control.

In 2024, Opill arrives on store shelves and can be purchased without a prescription. Dr. Raegan McDonald-Mosley — CEO of Power to Decide and one of the nation’s top medical leaders on access to reproductive health — talks about what’s really in this little pill, its safety, and what the medical community thinks about it. Dr. Raegan also predicts the significant opportunities Opill’s launch will offer to millions of people in the U.S. who face systemic barriers to reproductive health care, including living in contraceptive deserts, economic inequities, and more.

Dr. Raegan McDonald-Mosley, OB-GYN and Power to Decide's CEO, explains the basics of how pregnancy begins, the difference between fertilization and implementation, and why it all matters so much.

In a media landscape permeated with misinformation and disinformation about reproductive health, it is crucial to distinguish facts from myths. Dr. Raegan McDonald-Mosley, Power to Decide’s CEO, debunks six myths and provides clarity about the birth control pill, which is backed by decades of scientific research underscoring its safety and effectiveness.